238 related articles for article (PubMed ID: 29952659)
1. Treatment of inflammatory myopathies.
Pipitone N; Salvarani C
Expert Rev Clin Immunol; 2018 Jul; 14(7):607-621. PubMed ID: 29952659
[TBL] [Abstract][Full Text] [Related]
2. The possible role of physical exercise on the treatment of idiopathic inflammatory myopathies.
de Salles Painelli V; Gualano B; Artioli GG; de Sá Pinto AL; Bonfá E; Lancha Junior AH; Lima FR
Autoimmun Rev; 2009 Mar; 8(5):355-9. PubMed ID: 19041955
[TBL] [Abstract][Full Text] [Related]
3. Up-to-date treatment and management of myositis.
Pipitone N; Salvarani C
Curr Opin Rheumatol; 2020 Nov; 32(6):523-527. PubMed ID: 32890030
[TBL] [Abstract][Full Text] [Related]
4. Dermatomyositis and polymyositis: from immunopathology to immunotherapy (immunobiologics).
Shinjo SK; de Souza FH; de Moraes JC
Rev Bras Reumatol; 2013 Feb; 53(1):101-10. PubMed ID: 23588520
[TBL] [Abstract][Full Text] [Related]
5. Update on the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease.
Dalakas MC
J Clin Immunol; 1995 Nov; 15(6 Suppl):70S-75S. PubMed ID: 8613495
[TBL] [Abstract][Full Text] [Related]
6. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
Lazarou IN; Guerne PA
J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
[TBL] [Abstract][Full Text] [Related]
7. Current diagnosis and treatment of polymyositis and dermatomyositis.
Sasaki H; Kohsaka H
Mod Rheumatol; 2018 Nov; 28(6):913-921. PubMed ID: 29669460
[TBL] [Abstract][Full Text] [Related]
8. Features of polymyositis and dermatomyositis in the elderly: a case-control study.
Pautas E; Chérin P; Piette JC; Pelletier S; Wechsler B; Cabane J; Herson S
Clin Exp Rheumatol; 2000; 18(2):241-4. PubMed ID: 10812498
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 and myositis - unique challenges for patients.
Gupta L; Lilleker JB; Agarwal V; Chinoy H; Aggarwal R
Rheumatology (Oxford); 2021 Feb; 60(2):907-910. PubMed ID: 33175137
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic advances in myositis.
Aggarwal R; Oddis CV
Curr Opin Rheumatol; 2012 Nov; 24(6):635-41. PubMed ID: 22955021
[TBL] [Abstract][Full Text] [Related]
11. Biologic therapy in the idiopathic inflammatory myopathies.
Khoo T; Limaye V
Rheumatol Int; 2020 Feb; 40(2):191-205. PubMed ID: 31680207
[TBL] [Abstract][Full Text] [Related]
12. Biologics in refractory myositis: experience in juvenile vs. adult myositis; part II: emerging biologic and other therapies on the horizon.
Patwardhan A; Spencer CH
Pediatr Rheumatol Online J; 2019 Aug; 17(1):56. PubMed ID: 31429786
[TBL] [Abstract][Full Text] [Related]
13. [Idiopathic Inflammatory Myopathies].
Tomaras S; Kekow J; Feist E
Dtsch Med Wochenschr; 2020 Jul; 145(13):903-910. PubMed ID: 32615605
[TBL] [Abstract][Full Text] [Related]
14. [Idiopathic inflammatory myopathies: main clinical and immunological variants, difficulties of differential diagnostics and therapy].
Antelava OA; Nasonov EL
Klin Med (Mosk); 2014; 92(3):19-25. PubMed ID: 25269190
[TBL] [Abstract][Full Text] [Related]
15. WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
Choy EH; Hoogendijk JE; Lecky B; Winer JB; Gordon P
Cochrane Database Syst Rev; 2009 Oct; (4):CD003643. PubMed ID: 19821312
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
Choy EH; Hoogendijk JE; Lecky B; Winer JB
Cochrane Database Syst Rev; 2005 Jul; (3):CD003643. PubMed ID: 16034905
[TBL] [Abstract][Full Text] [Related]
17. Using multi-omics methods to understand dermatomyositis/polymyositis.
Gao S; Luo H; Zhang H; Zuo X; Wang L; Zhu H
Autoimmun Rev; 2017 Oct; 16(10):1044-1048. PubMed ID: 28778709
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic strategies in idiopatic inflammatory myopathies].
Chakour R; Leimgruber A; Bart PA; Spertini F
Rev Med Suisse; 2009 Apr; 5(199):812-8. PubMed ID: 19441746
[TBL] [Abstract][Full Text] [Related]
19. Dermatomyositis and polymyositis: new treatment targets on the horizon.
Hak AE; de Paepe B; de Bleecker JL; Tak PP; de Visser M
Neth J Med; 2011 Oct; 69(10):410-21. PubMed ID: 22058260
[TBL] [Abstract][Full Text] [Related]
20. Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies.
de Souza FHC; Miossi R; de Moraes JCB; Bonfá E; Shinjo SK
Adv Rheumatol; 2018 Sep; 58(1):31. PubMed ID: 30657080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
